ANZCTR - Registration

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers

Trial registered on ANZCTR

Registration number

ACTRN12617000457347

Ethics application status

Approved

Date submitted

26/10/2016

Date registered

28/03/2017

Date last updated

5/09/2022

Date data sharing statement initially provided

5/09/2022

Type of registration

Prospectively registered

Titles & IDs

Public title

LifeSpan: A whole-population stepped-wedge cluster-randomized trial of a multilevel systems approach to reduce suicide attempts and deaths in four NSW regions.

Scientific title

LifeSpan: A stepped-wedge cluster-randomized trial of a multi-level systems approach to suicide prevention, including means restrictions, community based campaigns and enhanced identification and treatment of suicidal individuals to reduce suicide attempts and deaths in individuals of all ages in four sites in New South Wales.

Secondary ID [1]

None

Universal Trial Number (UTN)

U1111-1190-0793

Trial acronym

Linked study record

Health condition

Health condition(s) or problem(s) studied:

Suicide

Intentional self-harm

indigenous mental health

youth mental health

men's mental health

women's mental health

Condition category

Condition code

Mental Health

Suicide

Intervention/exposure

Study type

Interventional

Description of intervention(s) / exposure

LifeSpan is a large-scale, community-wide trial for suicide prevention that will be implemented in four sites within New South Wales. LifeSpan will involve implementing nine strategies ranging from universal interventions to indicated interventions. The interventions will be implemented in each of the four trial sites for a period of two years, with evaluation occurring at 12-months and 24-months after baseline. Each site has a minimum population of 140,000 and its own local implementation team so that interventions, whilst maintaining core features for effectiveness, may be implemented differently to suit the local environment. The four sites are supported by a central implementation team and a research team based at the Black Dog Institute.

The universal strategies include:
1. Means restriction: A suicide audit will be conducted, which will include the analysis of coronial and police data to assess trends, access to means and other contextual factors contributing to suicides and suicide attempts, at each of the four sites. The suicide audit will inform recommendations for tailored means restrictions strategies to reduce further suicide attempts and deaths in each of the four sites. The suicide audit will be supplemented by a focus group with professionals (e.g. hospital emergency department staff, community mental health staff) who have local knowledge of any suicide clusters in their community and what measures have been taken to deal with the risk. The site lead agencies and suicide prevention collaboratives will be provided with a guide to evidence-based strategies to reduce access to or lethality of means. The Black Dog Institute and the sites will work collaboratively to develop means restrictions strategies, based on the evidence-based guide. Strategies will also be guided by the dominant means identified, local needs, and local stakeholders relevant to facilitating specific means restriction. All means restriction actions will be documented for trial evaluation purposes.

2. School programs: Year nine high school students in all public, independent, and Catholic high schools within the four sites will be offered an evidence-based, universal school program designed to reduce stigma, increase help seeking behaviours and resilience, and reduce suicidal ideation and behaviours. YAM will be delivered over the two-year duration of the LifeSpan trial, meaning two consecutive cohorts of year 9 students will receive the YAM program.

The intervention being used is Youth Aware Mental Health (YAM), which is a school-based suicide prevention program delivered by trained facilitators from outside of the school. YAM was developed by researchers and clinicians from the Karolinska Institute in Sweden and Cornell University in the US. Its primary aim is to raise awareness about suicide risk and the factors that may protect against suicidality. YAM will be delivered as per the SEYLE study protocol: Master trainers will travel from US and Europe to conduct a 4.5 day course to certify YAM instructors. YAM instructors will identify helpers and conduct half- day helper training. The helper can either be another accredited instructor, relevant youth worker or person with lived experience. YAM consists of five sessions delivered over a three-week period. These sessions include a mix of direct instruction, reading material, visual information and interactive workshops where young people are encouraged to role play skills within a supervised environment. The program is delivered by the accredited YAM instructors with the aid of one helper to class groups of up to approximately 30 students.
The five sessions cover the following six central themes: what is mental health?; self-help advice; stress and crisis; depression and suicidal thoughts; helping a friend in need; and who can I ask for advice?

3. Community campaigns: Centrally developed resources and materials, created with the assistance of a media and advertising agency and containing key consistent messages, will be disseminated within each of the four sites. Locally delivered communications campaigns will be disseminated to the general public to reduce stigma, and to increase identification and referral of individuals with suicidal ideation or self-harming behaviours. In addition, sites will be provided with a budget and support to engage with existing suicide prevention campaign providers, such as beyondblue and R U OK, to deliver their campaigns within their region. Number of type of activities will be recorded for evaluation purposes.

4. Media guidelines: Journalists, media representatives and local health services will receive group-based face-to-face media training, delivered by MindFrame Australia, aimed at reducing dangerous reporting of suicide, and increasing responsible coverage of mental health and suicide. Local media organisations will be targeted to ensure sufficient training in, and compliance with, these guidelines, including: report suicide deaths in a sensitive and non-sensationalist manner; avoid giving suicide deaths undue prominence (e.g. front page of newspaper, or lead items in radio bulletins); prevent ‘copycat’ incidents, avoid providing specific details about the suicide, such as method or location; take the opportunity to educate the public and challenge myths about suicide; provide help and support resources to vulnerable viewers, such as listing crisis and helpline numbers; consider the needs of at-risk individuals in the aftermath of a suicide (e.g. taking care when interviewing the bereaved); provide opportunities for debriefing of those exposed to suicide stories, such as journalists themselves. The target audience is local media representatives, suicide prevention multiagency group members, organisational leaders and local leaders who might be asked to comment on suicide by media and who are involved in community support after suicide. A 2-day, face-to-face group program will be delivered early in year 1 of implementation at each site, with a half day refresher program delivered in year 2.

The individual-based strategies are:
5. Gatekeepers (e.g. sports coaches, pharmacists, welfare workers) will receive training to identify and refer individuals with suicidal ideation or self-harming behaviour. Training will be provided to gatekeepers in each of the four sites in both face-to-face and online format. Gatekeeper training teaches lay and professional gatekeepers to recognise and respond positively to someone exhibiting suicide warning signs and behaviours, including providing appropriate referral information. The program includes orientation to suicide prevention and the role of gatekeepers, a review of the common myths about suicide, review and recognition of suicide warning signs, instruction on how to set up an intervention and how to ask the suicide question, how to persuade a suicidal person to accept help, how to refer a suicidal person to local/national resources, and how to improve self-efficacy and enhance hope by offering a personal belief in a positive outcome. One hundred gatekeepers will be trained per region.

6. Frontline staff training: First responders (police, paramedics, and emergency department staff) will receive face to face and online training to support individuals with suicidal ideation or self-harming behaviours. Training will be provided to first responders in each of the four sites. Where training already exists, such as the NSW Police Mental Health IT program, support will be offered to ensure the program is meeting local needs. Other frontline staff, such as emergency department staff, will be offered tailored training which includes gatekeeper skills but also addresses their particular needs. The local implementation teams have identified key decision makers within each sector to work with them in implementing training. The total number of staff trained will vary by sector and site.

7. Psychosocial treatments: A guide to evidence-based psychological and pharmacological treatments for the care of individuals with suicidal ideation and/or behaviours will be provided to privately and publicly employed psychologists, psychiatrists, and other mental health professionals at each site. The Advanced Suicide Prevention Training program, designed and facilitated by the Black Dog Institute, will be provided for these professionals, to inform appropriate assessment of suicidal ideation and/or behaviours. This 6 hour face-to-face group program trains participants to undertake a suicide risk assessment effectively; develop a collaborative safety plan; implement a team approach to treatment planning; provide effective management following a suicide attempt; and respond to the needs of people bereaved by suicide. This training will be supplemented by information on local referral pathways, delivered by a local subject matter expert and program champion. We aim to train 200 mental health professionals at each of the four sites.

8. GP capacity building and support: General practitioners will receive training and practice support to identify and refer individuals with suicidal ideation or self-harming behaviours. The Advanced Suicide Prevention Training program, designed and facilitated by the Black Dog Institute, will be provided to general practitioners. This 6 hour face-to-face group-based program trains participants to undertake a suicide risk assessment effectively; develop a collaborative safety plan; implement a team approach to treatment planning; provide effective management following a suicide attempt; and respond to the needs of people bereaved by suicide.

Practice support is in the form of an electronically delivered stepped care program. General practices will be provided with training by the Black Dog Institute developers of the program (StepCare). Participating ractices will be provided with tablets to be placed in the waiting room. Practice staff will invite patients over the age of 18 years to complete a 2-minute screener in the waiting room on a mobile tablet. The patient is provided with information about StepCare and is asked to provide consent prior to progressing. If consent is provided, the patient will be asked to complete demographic information and questionnaires assessing anxiety, depression, alcohol use, suicidal ideation and risk. The patient will receive minimal immediate feedback and will be encouraged to discuss the results with their GP in detail. The GP will also be provided with more detailed immediate feedback, verbal scripts and recommendations for the patient within the practice management software. The recommended treatment steps up for more severe symptoms. The program automatically populates a Medicare Mental Health Treatment Plan if required. Patients who report symptoms are asked to complete screening every two weeks for 12 weeks, and these results are transmitted back to their GP so that the treatment plan can be modified if necessary. Training for the general practice staff in StepCare will come from a trainer located within the Primary Health Network, who will have received ‘train-the-trainer’ from the Black Dog Institute StepCare coordinator. We aim to train and/or provide StepCare access to 50-60 general practitioners per site.

9. Aftercare and crisis care following a suicide attempt: The reform of care in the emergency department and aftercare will be ongoing through the two-year implementation phase of the project. Guidelines will be developed regarding most appropriate aftercare and crisis care. These guidelines will be implemented in collaboration with hospitals, community mental health centres, and others involved in aftercare in each of the four sites. The guidelines will include recommendations for completing a psychosocial assessment for all patients who present at hospital following a suicide attempt (not just those considered high-risk), explicit communication to the patient about the role of the psychosocial assessment, and an emphasis on the relational aspects of the assessment. With the patient’s consent, families and carers will be included in the aftercare process. Each site has or will commission an aftercare support service which is based on the Outreach, Problem Solving, Adherence, and Continuity (OPAC) model, which includes assertive outreach, solution focused counselling, support to adhere to treatment, and where possible, continuity of contact with the same staff member.

Intervention code [1]

Prevention

Intervention code [2]

Behaviour

Comparator / control treatment

As the study is utilising a stepped-wedge design, each site has a baseline period which acts as its own control.

Control group

Active

Outcomes

Primary outcome [1]

Number of suicide attempts as indexed by hospital-treated self-harm over time. The baseline period will be from January 2012 to the start of implementation for each site, Two linked datasets will be used to measure the outcome: the Emergency Department Data Collection (EDDC; annotated version) and the Admitted Patient Data Collection (APDC).

Timepoint [1]

Data will be acquired at baseline and, at a minimum, up to 24 months post-baseline.

Primary outcome [2]

Number of suicide deaths over time. The baseline period will be from January 2012 to the start of implementation for each site. This outcome will be measured using the Cause of Death unit record file from the New South Wales Registry of Births Deaths and Marriages.

Timepoint [2]

Data will be acquired at baseline and, at a minimum, up to 24 months post-baseline.

Secondary outcome [1]

Changes in community level suicide stigma (Stigma of Suicide Scale), measured via community-wide online survey.

Timepoint [1]

Measurement will occur at baseline and at 24 months post-baseline.

Secondary outcome [2]

Changes in community level suicide literacy (Literacy of Suicide Scale) measured via community-wide online survey.

Timepoint [2]

Measurement will occur at baseline and at 24 months post-baseline.

Secondary outcome [3]

Changes in community level help-seeking behaviours (Actual Help-Seeking Questionnaire) measured via community-wide online survey.

Timepoint [3]

Measurement will occur at baseline and at 24 months post-baseline.

Secondary outcome [4]

Changes in community level suicidality (Suicidal Ideation Assessment Scale) measured via community-wide online survey.

Timepoint [4]

Measurement will occur at baseline and at 24 months post-baseline.

Secondary outcome [5]

Changes in community level depression (PHQ-9) measured via community-wide online survey.

Timepoint [5]

Measurement will occur at baseline and at 24 months post-baseline.

Secondary outcome [6]

Changes in number of repeat episodes of hospital-treated deliberate self-harm, measured using linked, routinely collected data (the New South Wales Admitted Patient Dataset, admissions for self-harm and the Emergency Department Data Collection presentations for self-harm.

Timepoint [6]

Data will be acquired over the two-year duration of the intervention.

Secondary outcome [7]

Changes in risk of repeat deliberate self-harm or suicide attempt following hospital treated deliberate self-harm, measured using NSW Health hospital admissions data and self-report and the Emergency Department Data Collection presentations for self-harm.

Timepoint [7]

Measurement will occur at baseline and at 24 months post-baseline.

Secondary outcome [8]

Changes in patient satisfaction with health services following a suicide attempt, measured by Your Experience of Services Survey and in-depth interviews.

Timepoint [8]

Measurement will occur at baseline and 12 months post-baseline.

Secondary outcome [9]

Changes in access to evidence-based psychological treatment for mental ill health, using data from the Medicare Benefits Scheme data.

Timepoint [9]

Data will be acquired, comparing outcomes, from 24months prior to the intervention, through to 24months post-baseline.

Secondary outcome [10]

Changes in prescribing practices for depression, anxiety, and suicidality, measured by data from the Pharmaceutical Benefits Scheme data.

Timepoint [10]

Data will be acquired over the two-year duration of the intervention.

Secondary outcome [11]

Changes in community gatekeeper confidence to identity suicide risk, as measured by self-report data using an online survey.

Timepoint [11]

Measurement will occur at pre- and post-training, and 12months after the training.

Secondary outcome [12]

Changes in community gatekeeper responses to suicide risk, measured by self-report data from a measure of referral behaviours.

Timepoint [12]

Measurement will occur at pre- and post-training, and 12months after the training.

Secondary outcome [13]

Changes in community gatekeeper suicide literacy, measured by self-report data from the Literacy of Suicide Scale (LOSS).

Timepoint [13]

Measurement will occur at pre- and post-training, and 12months after the training.

Secondary outcome [14]

Changes in community gatekeeper suicide stigma, measured by self-report data from the Stigma of Suicide Scales (SOSS).

Timepoint [14]

Measurement will occur at pre- and post-training, and 12months after the training.

Secondary outcome [15]

Changes in high-school students’ suicide behaviour and suicidal ideation, by self-report data from Paykel's Suicidal Feelings in the General Population Questionnaire, and two additional questions have been added asking ‘Have you ever tried to take their own life?’, and if so, if this occurred in the past two weeks, the past year, or earlier.

Timepoint [15]

Measurement will occur at pre-program and 3 and 6 months post-program.

Secondary outcome [16]

Changes in high-school students’ attitudes to and actual help seeking, by self-report data from the General Help-Seeking Questionnaire and Actual Help-Seeking Questionnaire.

Timepoint [16]

Measurement will occur at pre-program and 3 and 6 months post-program.

Secondary outcome [17]

Changes in high-school students’ risk behaviour by self-report data from the Youth Risky Behaviour Survey.

Timepoint [17]

Measurement will occur at pre-program and 3 and 6 months post-program.

Secondary outcome [18]

Changes in high-school students’ suicide stigma by self-report data from the Stigma of Suicide Scale (SOSS).

Timepoint [18]

Measurement will occur at pre-program and 3 and 6 months post-program.

Secondary outcome [19]

Changes in high-school students’ suicide literacy by self-report data from the Literacy of Suicide Scale (LOSS).

Timepoint [19]

Measurement will occur at pre-program and 3 and 6 months post-program.

Secondary outcome [20]

Change in stigmatising or harmful reporting of suicide by local media, measured by media monitoring.

Timepoint [20]

Measurement will occur over the two-year duration of the intervention.

Secondary outcome [21]

Changes in suicide reporting which encourages help-seeking or covers stories of recovery by local media, measured by media monitoring.

Timepoint [21]

Measurement will occur over the two-year duration of the intervention.

Secondary outcome [22]

To evaluate the cost effectiveness of LifeSpan on reducing suicide mortality and suicide attempt rates compared to current practice. This will include calculating differences in the number of suicides and suicide attempts for the intervention and control groups, and comparing these to differences in resource use costs associated with program delivery and management, and primary and clinical mental health services. Data on benefits and costs will be collected from hospital and government administrative datasets. Results will be presented through Incremental Cost Effectiveness Ratios (ICERs) as the cost per suicide avoided, cost per suicide attempt avoided, and cost per life-year gained. Benefits and costs will be categorised into government, non-government and patient for presentation purposes.

Timepoint [22]

Outcomes will be measured over the two-year duration of the intervention.

Secondary outcome [23]

Changes in access to suicide means, measured via a suicide audit (using NCIS data, Admitted Patient Data Collection) and geospatial analysis of clusters.

Timepoint [23]

Data will be acquired over the two-year duration of the intervention.

Eligibility

Key inclusion criteria

All residents in each of the four trial sites will be eligible for inclusion in the study, given the universal nature of some of the strategies.

Minimum age

No limit

Maximum age

No limit

Sex

Both males and females

Can healthy volunteers participate?

Yes

Key exclusion criteria

Nil.

Study design

Purpose of the study

Prevention

Allocation to intervention

Randomised controlled trial

Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)

Methods used to generate the sequence in which subjects will be randomised (sequence generation)

Masking / blinding

Open (masking not used)

Who is / are masked / blinded?

Intervention assignment

Other

Other design features

The trial is utilising a stepped-wedge design in which the time at which the intervention was scheduled for introduction at each of the four trial sites was selected randomly without replacement from a pool of four possible start dates. This established cascading start dates for the sites. Pre-intervention (baseline) measures of each outcome measure (primary and secondary) will be taken prior to implementation of the intervention. Where possible, institutionally-supplied outcome measures will be collected at each site over the entire span of the trial.

Phase

Not Applicable

Type of endpoint/s

Statistical methods / analysis

Recruitment

Recruitment status

Completed

Date of first participant enrolment

Anticipated

1/04/2017

Actual

1/08/2017

Date of last participant enrolment

Anticipated

Actual

31/12/2020

Date of last data collection

Anticipated

Actual

31/12/2020

Sample size

Target

25000

Accrual to date

Final

25065

Recruitment in Australia

Recruitment state(s)

NSW

Funding & Sponsors

Funding source category [1]

Charities/Societies/Foundations

Name [1]

Paul Ramsay Foundation

Address [1]

Level 9, 154 Pacific Highway
St Leonards NSW 2065

Country [1]

Australia

Primary sponsor type

University

Name

Black Dog Institute/UNSW

Address

Hospital Road
Randwick NSW 2031

Country

Australia

Secondary sponsor category [1]

None

Name [1]

n/a

Address [1]

n/a

Country [1]

Ethics approval

Ethics application status

Approved

Ethics committee name [1]

Hunter New England Human Research Ethics Committee

Ethics committee address [1]

Research Ethics and Governance Office
Hunter New England Human Research Ethics Committee
Hunter New England Local Health District
Locked Bag 1
New Lambton NSW 2305

Ethics committee country [1]

Australia

Date submitted for ethics approval [1]

21/09/2016

Approval date [1]

12/10/2016

Ethics approval number [1]

HREC/16/HNE/399

Ethics committee name [2]

NSW Population & Health Services Research Ethics Committee

Ethics committee address [2]

Locked Bag 2030, St Leonards NSW 1590

Ethics committee country [2]

Australia

Date submitted for ethics approval [2]

09/07/2020

Approval date [2]

17/12/2020

Ethics approval number [2]

2020/ETH01527 / 2019.62

Ethics committee name [3]

Justice Human Research Ethics Committee

Ethics committee address [3]

Department of Justice and Community Safety
GPO Box 4356
Melbourne VIC 3001

Ethics committee country [3]

Australia

Date submitted for ethics approval [3]

11/04/2017

Approval date [3]

01/06/2017

Ethics approval number [3]

CF/17/10447

Summary

Brief summary

Background: Lifespan is the systems approach to suicide prevention developed by Black Dog Institute (BDI) and the NHMRC Centre for Research Excellence in Suicide Prevention. BDI is undertaking an evaluation of the LifeSpan approach in four sites across NSW, funded by the Paul Ramsay Foundation and with the support of the NSW Government and the NSW Mental Health Commission. LifeSpan includes nine evidence-based interventions implemented simultaneously within a localised region. Recognising that multiple strategies implemented at the  same time are likely to generate bigger effects than just the sum of its parts (i.e., due to synergistic effects), LifeSpan offers a data driven, evidence-based approach, setting it apart from current practise and raising the bar in suicide prevention. Based on the most up-to-date evidence available and drawing from positive results of similar suicide prevention programs overseas, this integrated systems approach is expected to prevent 20% of suicide deaths, and 30% of suicide attempts. 
Design: LifeSpan involves a stepped-wedge, randomised design whereby the intervention will be sequentially rolled-out in each of the four sites at three month intervals. This design will avoid the effect of the intervention being confounded with any underlying temporal trend. Once rolled-out, the intervention will be active in each site for two years. 
Methods: LifeSpan will involve implementing nine intervention strategies. The individual-based strategies include: aftercare and crisis care, psychosocial and pharmacotherapy treatments, GP capacity building and support, frontline staff training, and gatekeeper training. The universal strategies include: school programs, community campaigns, media guidelines and means restriction. Furthermore, the project will include a community, professionals, and key stakeholder self-report measures. The project will incorporate and be measured against an Implementation Science framework, to ensure maximum engagement and fidelity to the model.

Trial website

https://www.blackdoginstitute.org.au/research-centres/lifespan-trials/

Trial related presentations / publications

2022
Burnett, A., Chen, N., Zeritis, S., Ware, S., McGillivray, L., Shand, F., & Torok, M. (2022). Machine learning algorithms to classify self-harm behaviours in New South Wales Ambulance electronic medical records: A retrospective study. International journal of medical informatics, 161, 104734.

Long, J. C., Ruane, C., Ellis, L. A., Lake, R., Le Roux, A., Testa, L., ... & Zurynski, Y. (2022). Networks to strengthen community social capital for suicide prevention in regional Australia: the LifeSpan suicide prevention initiative. International journal of mental health systems, 16(1), 1-16.

Rheinberger, D., Wang, J., McGillivray, L., Shand, F., Torok, M., Maple, M., & Wayland, S. (2022). Understanding emergency department healthcare professionals' perspectives of caring for individuals in suicidal crisis: a qualitative study. Frontiers in psychiatry, 13.
	
Zbukvic, I., Rheinberger, D., Rosebrock, H., Lim, J., McGillivray, L., Mok, K., ... & Moullin, J. C. (2022). Developing a tailored implementation action plan for a suicide prevention clinical intervention in an Australian mental health service: A qualitative study using the EPIS framework. Implementation Research and Practice, 3, 26334895211065786.

2021
Edwards, T., Torok, M., McGillivray, L., Ford, T., Mok, K., Li, E., & Larsen, M. E. (2021). Social media responses to online suicide-related news articles. Crisis: The Journal of Crisis Intervention and Suicide Prevention, 42(4), 309.

McGillivray, L., Shand, F., Calear, A. L., Batterham, P. J., Rheinberger, D., Chen, N. A., ... & Torok, M. (2021). The Youth Aware of Mental Health program in Australian secondary schools: 3-and 6-month outcomes. International journal of mental health systems, 15(1), 1-9.

McGillivray, L., Shand, F., Calear, A. L., Batterham, P. J., Chen, N. A., Rheinberger, D., ... & Torok, M. (2021). Profiles of passive and active suicidal ideation and attempts among secondary school students in Australia: a cross-sectional analysis. Archives of suicide research, 1-15.

Mok, K., Chen, N., Torok, M., McGillivray, L., Zbukvic, I., & Shand, F. (2021). Factors associated with help-seeking for emotional or mental health problems in community members at risk of suicide. Advances in Mental Health, 19(3), 236-246.

Rasmussen, V., Steel, Z., Spangaro, J., & Torok, M. (2021). Investigating the prevalence of intimate partner violence victimisation in women presenting to the emergency department in suicidal crisis. Emergency Medicine Australasia, 33(4), 703-710.

Rheinberger, D., Shand, F., Mok, K., McGillivray, L., Maple, M., Burnett, A., ... & Torok, M. (2021). A qualitative analysis of motivators to participation in suicide-focused research from a community-based Australian sample. International journal of environmental research and public health, 18(9), 4705.

Rheinberger, D., Macdonald, D., McGillivray, L., Maple, M., Torok, M., Nicolopoulos, A., & Shand, F. (2021). “A Sustained, Productive, Constructive Relationship with Someone Who Can Help”—A Qualitative Exploration of the Experiences of Help Seekers and Support Persons Using the Emergency Department during a Suicide Crisis. International journal of environmental research and public health, 18(19), 10262.


Rimkeviciene, J., Mok, K., Shand, F., Hawgood, J., & O'Gorman, J. (2021). Validity of the Personal Suicide Stigma Questionnaire in a community sample. European journal of psychological assessment

Rosebrock, H. Y., Batterham, P. J., Chen, N. A., McGillivray, L., Rheinberger, D., Torok, M. H., & Shand, F. L. (2021). Nonwillingness to return to the emergency department and nonattendance of follow-up care arrangements following an initial suicide-related presentation. Crisis: The Journal of Crisis Intervention and Suicide Prevention.

2020
Lee, S., Torok, M., Shand, F., Chen, N., McGillivray, L., Burnett, A., ... & Mok, K. (2020). Performance, cost-effectiveness, and representativeness of Facebook recruitment to suicide prevention research: online survey study. JMIR mental health, 7(10), e18762.

McGillivray, L., Torok, M., Calear, A., Shand, F., Mackinnon, A., Kuhnert, R. L., ... & Christensen, H. (2020). Suicide prevention among young people: A study protocol for evaluating Youth Aware of Mental Health in Australian secondary schools. Mental Health & Prevention, 17, 200178.

Riley, J., Mok, K., Larsen, M., Boydell, K., Christensen, H., & Shand, F. (2020). Meeting the Needs of Those in Suicidal Crisis With new Models and Integrated Care. What can be Done to Decrease Suicidal Behaviour in Australia, 1-14.

Rosebrock, H., Chen, N., Tye, M., Mackinnon, A., Calear, A. L., Batterham, P. J., ... & Shand, F. (2020). Study protocol for a mixed methods prospective cohort study to explore experiences of care following a suicidal crisis in the Australian healthcare system. BMJ open, 10(8), e033814.

Shand, F., Torok, M., Cockayne, N., Batterham, P. J., Calear, A. L., Mackinnon, A., ... & Christensen, H. (2020). Protocol for a stepped-wedge, cluster randomized controlled trial of the LifeSpan suicide prevention trial in four communities in New South Wales, Australia. Trials, 21(1), 1-10.

Zbukvic, I. C., Mok, K., McGillivray, L., Chen, N. A., Shand, F. L., & Torok, M. H. (2020). Understanding the process of multilevel suicide prevention research trials. Evaluation and program planning, 82, 101850.


2019
Hill, N., Shand, F., Torok, M., Halliday, L., & Reavley, N. J. (2019). Development of best practice guidelines for suicide-related crisis response and aftercare in the emergency department or other acute settings: a Delphi expert consensus study. BMC psychiatry, 19(1), 1-10.

Torok, M., Shand, F., Phillips, M., Meteoro, N., Martin, D., & Larsen, M. (2019). Data-informed targets for suicide prevention: a small-area analysis of high-risk suicide regions in Australia. Social psychiatry and psychiatric epidemiology, 54(10), 1209-1218.

2018
Baker, S. T., Nicholas, J., Shand, F., Green, R., & Christensen, H. (2018). A comparison of multi-component systems approaches to suicide prevention. Australasian Psychiatry, 26(2), 128-131.

Shand, F., Vogl, L., & Robinson, J. (2018). Improving patient care after a suicide attempt. Australasian psychiatry, 26(2), 145-148.



2017
Hill, N., Halliday, L., & Reavley, N. J. (2017). Guidelines for integrated suicide-related crisis and follow-up care in Emergency Departments and other acute settings. Australia: Black Dog Institute.

Torok, M., Calear, A., Shand, F., & Christensen, H. (2017). A systematic review of mass media campaigns for suicide prevention: understanding their efficacy and the mechanisms needed for successful behavioral and literacy change. Suicide and Life-Threatening Behavior, 47(6), 672-687.


2016
Christensen, H., Cuijpers, P., & Reynolds, C. F. (2016). Changing the direction of suicide prevention research: a necessity for true population impact. JAMA psychiatry, 73(5), 435-436.

Krysinska, K., Batterham, P. J., Tye, M., Shand, F., Calear, A. L., Cockayne, N., & Christensen, H. (2016). Best strategies for reducing the suicide rate in Australia. Australian & New Zealand Journal of Psychiatry, 50(2), 115-118.

Public notes

Contacts

Principal investigator

Name

Prof Helen Christensen

Address

Black Dog Institute
Hospital Road
Randwick NSW 2031

Country

Australia

Phone

+61 2 9382 9288

Fax

h.christensen@blackdog.org.au

Contact person for public queries

Name

Fiona Shand

Address

Black Dog Institute
Hospital Road
Randwick NSW 2031

Country

Australia

Phone

+61 2 9065 9094

Fax

fionas@unsw.edu.au

Contact person for scientific queries

Name

Fiona Shand

Address

Black Dog Institute
Hospital Road
Randwick NSW 2031

Country

Australia

Phone

+61 2 9065 9094

Fax

fionas@unsw.edu.au

Data sharing statement

Will individual participant data (IPD) for this trial be available (including data dictionaries)?

No/undecided IPD sharing reason/comment

What supporting documents are/will be available?

Doc. No.	Type	Citation	Link	Email	Other Details	Attachment
17086	Study protocol	Shand, F., Torok, M., Cockayne, N., Batterham, P. J., Calear, A. L., Mackinnon, A., ... & Christensen, H. (2020). Protocol for a stepped-wedge, cluster randomized controlled trial of the LifeSpan suicide prevention trial in four communities in New South Wales, Australia. Trials, 21(1), 1-10.	https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-020-04262-w

Results publications and other study-related documents

Documents added manually

No documents have been uploaded by study researchers.

Documents added automatically

Source	Title	Year of Publication	DOI
Embase	Development of best practice guidelines for suicide-related crisis response and aftercare in the emergency department or other acute settings: A Delphi expert consensus study.	2019	https://dx.doi.org/10.1186/s12888-018-1995-1
Embase	Protocol for a stepped-wedge, cluster randomized controlled trial of the LifeSpan suicide prevention trial in four communities in New South Wales, Australia.	2020	https://dx.doi.org/10.1186/s13063-020-04262-w

N.B. These documents automatically identified may not have been verified by the study sponsor.

Trial Review

Registering a new trial?

Documents added manually

Documents added automatically